Buy4

CV Sciences, Inc.

CVSI

Total Value

$114.8K

Net $114.8K bought

Filing Date

Sep 9, 2026

10 transactions

Purchases

$114.8K

10 transactions

Trade Summary

On Jul 16, 2026 through Aug 7, 2026, CHEEVER CHARLIE E III, 10% Owner, purchased $114.8K of CV Sciences, Inc. (CVSI) across 10 transactions. The filing covers Common Stock, $0.0001 par value per share and reflects net buying of $114.8K. Reported prices ranged from $0.02. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Price at the Time of the Trade

CVSI daily price with the insider's purchase marked at $0.02.

Bought near the 8-month low · the stock trades 2% lower today.

Price data is delayed and provided for context only — not investment advice.

Insider Information

Name: CHEEVER CHARLIE E III
Role: 10% Owner

Filing Details

Filing Date: Sep 9, 2026
Transaction Date: Jul 16, 2026
Accession Number: 0001202557-26-000005
Form Type: 4
Net Trading Amount: $114.8K

Non-Derivative Transactions

Date	Security	Shares	Price	Type	Value
Jul 16, 2026	Common Stock, $0.0001 par value per share	91,387	$0.02	Purchase	$1.8K
Jul 17, 2026	Common Stock, $0.0001 par value per share	749,000	$0.02	Purchase	$15.0K
Jul 21, 2026	Common Stock, $0.0001 par value per share	335,000	$0.02	Purchase	$6.7K
Jul 22, 2026	Common Stock, $0.0001 par value per share	272,500	$0.02	Purchase	$5.5K
Jul 24, 2026	Common Stock, $0.0001 par value per share	470,075	$0.02	Purchase	$9.4K
Jul 28, 2026	Common Stock, $0.0001 par value per share	1,830,000	$0.02	Purchase	$36.6K
Jul 29, 2026	Common Stock, $0.0001 par value per share	60,000	$0.02	Purchase	$1.2K
Jul 31, 2026	Common Stock, $0.0001 par value per share	1,730,000	$0.02	Purchase	$34.6K
Aug 4, 2026	Common Stock, $0.0001 par value per share	108,000	$0.02	Purchase	$2.2K
Aug 7, 2026	Common Stock, $0.0001 par value per share	94,854	$0.02	Purchase	$1.9K

Want live alerts when CHEEVER CHARLIE E III trades again?

Download Insider Trades to track CVSI, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHEEVER CHARLIE E III

(Last)

(First)

(Middle)

(Street)

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CV Sciences, Inc. [ CVSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, $0.0001 par value per share	07/16/2026		P		91,387	A	$0.02	20,999,282	D
Common Stock, $0.0001 par value per share	07/17/2026		P		749,000	A	$0.02	21,748,282	D
Common Stock, $0.0001 par value per share	07/21/2026		P		335,000	A	$0.02	22,083,282	D
Common Stock, $0.0001 par value per share	07/22/2026		P		272,500	A	$0.02	22,355,782	D
Common Stock, $0.0001 par value per share	07/24/2026		P		470,075	A	$0.02	22,825,857	D
Common Stock, $0.0001 par value per share	07/28/2026		P		1,830,000	A	$0.02	24,655,857	D
Common Stock, $0.0001 par value per share	07/29/2026		P		60,000	A	$0.02	24,715,857	D
Common Stock, $0.0001 par value per share	07/31/2026		P		1,730,000	A	$0.02	26,445,857	D
Common Stock, $0.0001 par value per share	08/04/2026		P		108,000	A	$0.02	26,553,857	D
Common Stock, $0.0001 par value per share	08/07/2026		P		94,854	A	$0.02	26,648,711	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	Charles E. Cheever III	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 4 as rendered by the SEC from accession 0001202557-26-000005.

CV Sciences, Inc.

Trade Summary

Price at the Time of the Trade

Company Information

Insider Information

Filing Details

Non-Derivative Transactions

Want live alerts when CHEEVER CHARLIE E III trades again?

SEC Form 4

SEC Filing

Price at the Time of the Trade

SEC Form 4